Lifeist Wellness Income Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Revenue	0.25	0.59	1.36	22.07	21.15
Revenue Growth (YoY)	-57.65%	-56.86%	-93.81%	4.36%	-15.77%
Cost of Revenue	0.19	0.38	0.6	17.11	21.03
Gross Profit	0.06	0.2	0.76	4.96	0.12
Selling, General & Admin	2.38	4.19	6.01	18.79	20.27
Research & Development	-	-	-	0.13	0.63
Operating Expenses	2.46	4.64	6.95	20.08	23.88
Operating Income	-2.4	-4.43	-6.19	-15.12	-23.76
Interest Expense	-0.01	-0.03	-0.02	-0	-0.1
Interest & Investment Income	0.05	0.04	-	-	-
Currency Exchange Gain (Loss)	0	-0.03	-0.01	0.01	-0.13
Other Non Operating Income (Expenses)	0.01	0.08	0.07	-1.16	2.4
EBT Excluding Unusual Items	-2.34	-4.38	-6.15	-16.27	-21.59
Merger & Restructuring Charges	-	-	-0.01	-0.08	0.11
Gain (Loss) on Sale of Investments	-0.6	0.32	0.12	-0.07	-0.59
Asset Writedown	-0.11	-	-	-2.5	-
Other Unusual Items	0.06	-	-	-	-
Pretax Income	-2.99	-4.05	-6.04	-18.92	-22.07
Income Tax Expense	-	-	-0.03	-0.22	0.16
Earnings From Continuing Operations	-2.99	-4.05	-6.02	-18.7	-22.23
Earnings From Discontinued Operations	-	2.61	-8.11	3.26	-1.57
Net Income to Company	-2.99	-1.45	-14.13	-15.44	-23.8
Net Income	-2.99	-1.45	-14.13	-15.44	-23.8
Net Income to Common	-2.99	-1.45	-14.13	-15.44	-23.8
Shares Outstanding (Basic)	38	32	24	21	20
Shares Outstanding (Diluted)	38	32	24	21	20
Shares Change (YoY)	19.20%	30.30%	17.17%	6.74%	20.41%
EPS (Basic)	-0.08	-0.05	-0.58	-0.74	-1.22
EPS (Diluted)	-0.08	-0.05	-0.58	-0.74	-1.22
Free Cash Flow	-2.9	-0.88	-2.45	-16.04	-18.64
Free Cash Flow Per Share	-0.08	-0.03	-0.10	-0.77	-0.96
Gross Margin	23.66%	34.77%	55.93%	22.47%	0.57%
Operating Margin	-961.10%	-753.04%	-453.30%	-68.52%	-112.38%
Profit Margin	-1198.99%	-245.51%	-1034.86%	-69.94%	-112.56%
Free Cash Flow Margin	-1162.82%	-148.98%	-179.73%	-72.68%	-88.17%
EBITDA	-2.39	-4.41	-6.13	-13.93	-22.73
EBITDA Margin	-	-	-	-63.13%	-107.48%
D&A For EBITDA	0.01	0.03	0.06	1.19	1.03
EBIT	-2.4	-4.43	-6.19	-15.12	-23.76
EBIT Margin	-	-	-	-68.52%	-112.38%
Revenue as Reported	-	-	-	22.07	21.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.